Joerg Reinhardt Vice Chairman of the Board of Directors and Lead Independent Director (non-executive, independent)

Joerg Reinhardt was elected to the Board of Directors of Swiss Re Ltd in 2017. He was appointed Lead Independent Director in July 2023 and Vice Chairman of the Board of Directors in April 2024. He is a member of the Governance, Nomination and Sustainability Committee and the Compensation Committee.

Professional experience

Joerg Reinhardt was Chairman of the Board of Directors of Novartis from 2013 to March 2025. He was also Chairman of the Board of Trustees of the Novartis Foundation. He was Chairman of the Board of Management and the Executive Committee of Bayer HealthCare AG from 2010 to 2013, and prior to that, held various executive positions at Novartis. He was Chief Operating Officer from 2008 to 2010, headed the Vaccines and Diagnostics Division from 2006 to 2008, and held a number of other senior roles, primarily in research and development, in the preceding years. Joerg Reinhardt started his career at Sandoz Pharma Ltd, a predecessor company of Novartis, in 1982.

Educational background

• PhD in Pharmaceutical Sciences, Saarland University, Germany

External mandates

• None